Each filer's latest filing for H5870P102 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
LSP 7 Cooperative UA
13G/A
|
11.8% |
4/29/2026
Event 3/31/2026
|
||
| LSP 7 Cooperatieve U.A. | 11.8% | |||
| LSP 7 Management B.V. | 11.8% | |||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (3) | ||||
|
Pivotal bioVenture Partners Fund I, L.P.
13G/A
|
4.9% |
11/14/2025
Event 9/30/2025
|
||
| Nan Fung Group Holdings Limited | 4.9% | |||
| NF Investment Holdings Limited | 4.9% | |||
| Nan Fung Life Sciences Holdings Limited | 4.9% | |||
| NFLS Platform Holdings Limited | 0.9% | |||
| NFLS Beta Limited | 0.9% | |||
| Pivotal Life Sciences Holdings Limited | 4.0% | |||
| Pivotal Partners Ltd | 4.0% | |||
| Pivotal bioVenture Partners Fund I U.G.P. Ltd. | 4.0% | |||
| Pivotal bioVenture Partners Fund I G.P., L.P. | 4.0% | |||
| Pivotal bioVenture Partners Fund I, L.P. | 4.0% | |||
|
BVCF IV, L.P.
13G/A
|
4.1% |
3/27/2026
Event 2/13/2026
|
||
| BVCF IV, L.P. | 4.1% | |||
| Beyeotech | 4.1% | |||
| BVCF IV GP, Ltd. | 4.1% | |||
| Zhi Yang | 4.1% | |||
| Brunnur vaxtarsjodur slhf 13G/A | 0% |
1/3/2025
Event 12/30/2024
|
||
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 16 | 3.36 M | $30.7M |
| 2026 Q2 | 59 | 23.2 M | $317M |
| 2026 Q1 | 57 | 20.1 M | $529M |
| 2025 Q4 | 41 | 18.1 M | $364M |
| 2025 Q3 | 20 | 10.9 M | $192M |
| 2025 Q2 | 24 | 5.11 M | $99.1M |
| 2025 Q1 | 21 | 4.98 M | $94.7M |
| 2024 Q4 | 13 | 3.49 M | $59.4M |
| 2024 Q3 | 11 | 3.01 M | $36.9M |
| 2024 Q2 | 13 | 3.33 M | $39.8M |
| 2024 Q1 | 10 | 3.39 M | $40.9M |
| 2023 Q4 | 9 | 3.98 M | $44.3M |
| 2023 Q3 | 10 | 2.92 M | $32.1M |
| 2023 Q2 | 11 | 3.13 M | $38.5M |
| 2023 Q1 | 7 | 3.12 M | $23.2M |